FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102587937> ?p ?o ?g. }

• W2102587937 endingPage "6283" @default.
• W2102587937 startingPage "6271" @default.
• W2102587937 abstract "Abstract Purpose: The treatment of cancer with oncolytic viruses primarily depends on the selective viral replication in cancer cells. However, a replication-incompetent hemagglutinating virus of Japan (HVJ; Sendai virus) envelope (HVJ-E) suppresses the growth of human cancer cells as effectively as replication-competent live HVJ without producing toxic effects in nonmalignant cells. Here, we analyze the molecular mechanism of the oncolytic activity of HVJ-E. Experimental Design: The molecules responsible for HVJ-E–induced cancer cell death were elucidated in prostate cancer cell lines, and the effect of HVJ-E on orthotopic prostate cancers was evaluated in nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice. Results: The liposome-mediated transfer of viral RNA genome fragments from HVJ-E suppressed the viability of prostate cancer cells but not the viability of the noncancerous prostate epithelium. Knockdown experiments using siRNAs showed that the cancer cell–selective killing induced by HVJ-E was mediated by retinoic acid–inducible gene I (RIG-I) and mitochondrial antiviral signaling protein (MAVS). Downstream of the RIG-I/MAVS pathway, both TNF-related apoptosis-inducing ligand (TRAIL) and Noxa were upregulated by HVJ-E in the castration-resistant prostate cancer cell line PC3 but not in the noncancerous prostate epithelial cell line PNT2. TRAIL siRNA but not Noxa siRNA significantly inhibited HVJ-E–induced cell death in PC3 cells. However, Noxa siRNA effectively suppressed HVJ-E–induced cell death in DU145 cells, another castration-resistant prostate cancer cell line, in which Noxa but not TRAIL was upregulated by HVJ-E. Furthermore, the orthotopic prostate cancers were dramatically eradicated in immunodeficient mice injected with HVJ-E. Conclusion: The RIG-I/MAVS signaling pathway represents an attractive target for cancer therapy. Clin Cancer Res; 18(22); 6271–83. ©2012 AACR." @default.
• W2102587937 created "2016-06-24" @default.
• W2102587937 creator A5013073310 @default.
• W2102587937 creator A5032407607 @default.
• W2102587937 creator A5036404247 @default.
• W2102587937 creator A5038224670 @default.
• W2102587937 creator A5040771019 @default.
• W2102587937 creator A5043158548 @default.
• W2102587937 creator A5084440905 @default.
• W2102587937 creator A5091657288 @default.
• W2102587937 date "2012-11-14" @default.
• W2102587937 modified "2023-09-27" @default.
• W2102587937 title "TRAIL and Noxa Are Selectively Upregulated in Prostate Cancer Cells Downstream of the RIG-I/MAVS Signaling Pathway by Nonreplicating Sendai Virus Particles" @default.
• W2102587937 cites W153540453 @default.
• W2102587937 cites W1963483847 @default.
• W2102587937 cites W1965497380 @default.
• W2102587937 cites W1969715620 @default.
• W2102587937 cites W1971195407 @default.
• W2102587937 cites W1976177182 @default.
• W2102587937 cites W1987506447 @default.
• W2102587937 cites W1991820728 @default.
• W2102587937 cites W1999379230 @default.
• W2102587937 cites W2009093968 @default.
• W2102587937 cites W2011125717 @default.
• W2102587937 cites W2012451630 @default.
• W2102587937 cites W2014960200 @default.
• W2102587937 cites W2023554850 @default.
• W2102587937 cites W2023942203 @default.
• W2102587937 cites W2024209265 @default.
• W2102587937 cites W2027522108 @default.
• W2102587937 cites W2029473602 @default.
• W2102587937 cites W2033077141 @default.
• W2102587937 cites W2035324885 @default.
• W2102587937 cites W2036368286 @default.
• W2102587937 cites W2041686632 @default.
• W2102587937 cites W2043103956 @default.
• W2102587937 cites W2047972729 @default.
• W2102587937 cites W2049092411 @default.
• W2102587937 cites W2051068137 @default.
• W2102587937 cites W2063512646 @default.
• W2102587937 cites W2065092867 @default.
• W2102587937 cites W2067761440 @default.
• W2102587937 cites W2076429505 @default.
• W2102587937 cites W2079647238 @default.
• W2102587937 cites W2084751672 @default.
• W2102587937 cites W2092735556 @default.
• W2102587937 cites W2100665873 @default.
• W2102587937 cites W2108595427 @default.
• W2102587937 cites W2124651203 @default.
• W2102587937 cites W2125845521 @default.
• W2102587937 cites W2140692786 @default.
• W2102587937 cites W2150048195 @default.
• W2102587937 cites W2161051851 @default.
• W2102587937 doi "https://doi.org/10.1158/1078-0432.ccr-12-1595" @default.
• W2102587937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23014529" @default.
• W2102587937 hasPublicationYear "2012" @default.
• W2102587937 type Work @default.
• W2102587937 sameAs 2102587937 @default.
• W2102587937 citedByCount "79" @default.
• W2102587937 countsByYear W21025879372013 @default.
• W2102587937 countsByYear W21025879372014 @default.
• W2102587937 countsByYear W21025879372015 @default.
• W2102587937 countsByYear W21025879372016 @default.
• W2102587937 countsByYear W21025879372017 @default.
• W2102587937 countsByYear W21025879372018 @default.
• W2102587937 countsByYear W21025879372019 @default.
• W2102587937 countsByYear W21025879372020 @default.
• W2102587937 countsByYear W21025879372021 @default.
• W2102587937 countsByYear W21025879372022 @default.
• W2102587937 countsByYear W21025879372023 @default.
• W2102587937 crossrefType "journal-article" @default.
• W2102587937 hasAuthorship W2102587937A5013073310 @default.
• W2102587937 hasAuthorship W2102587937A5032407607 @default.
• W2102587937 hasAuthorship W2102587937A5036404247 @default.
• W2102587937 hasAuthorship W2102587937A5038224670 @default.
• W2102587937 hasAuthorship W2102587937A5040771019 @default.
• W2102587937 hasAuthorship W2102587937A5043158548 @default.
• W2102587937 hasAuthorship W2102587937A5084440905 @default.
• W2102587937 hasAuthorship W2102587937A5091657288 @default.
• W2102587937 hasBestOaLocation W21025879372 @default.
• W2102587937 hasConcept C121608353 @default.
• W2102587937 hasConcept C159047783 @default.
• W2102587937 hasConcept C22615655 @default.
• W2102587937 hasConcept C2522874641 @default.
• W2102587937 hasConcept C2776438761 @default.
• W2102587937 hasConcept C2779723316 @default.
• W2102587937 hasConcept C2780127873 @default.
• W2102587937 hasConcept C2780192828 @default.
• W2102587937 hasConcept C3020616263 @default.
• W2102587937 hasConcept C502942594 @default.
• W2102587937 hasConcept C54009773 @default.
• W2102587937 hasConcept C54355233 @default.
• W2102587937 hasConcept C81885089 @default.
• W2102587937 hasConcept C82210918 @default.
• W2102587937 hasConcept C86803240 @default.
• W2102587937 hasConcept C96232424 @default.
• W2102587937 hasConceptScore W2102587937C121608353 @default.
• W2102587937 hasConceptScore W2102587937C159047783 @default.

• next